Pharmacological activities and pharmacokinetic study of hyperoside: A short review by Raza, Aun et al.
Raza et al 
Trop J Pharm Res, February 2017; 16(2): 483  
 
Tropical Journal of Pharmaceutical Research February 2017; 16 (2): 483-489 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 





Pharmacological activities and pharmacokinetic study of 
hyperoside: A short review 
 
Aun Raza, Xiuquan Xu, Huifang Sun, Jian Tang* and Zhen Ouyang 
School of Pharmacy, Jiangsu University, Zhenjiang 212013, China 
 
*For correspondence: Email: jt.u@hotmail.com; Tel/Fax: +86-511-85038201 
 
Received: 1 March 2016         Revised accepted: 13 September 2016 
 
Abstract 
Hyperoside (quercetin-3-O-D-galactoside) is a flavonol glycoside which has been isolated from different 
plants. It has different pharmacological actions such as anti-inflammatory, anti-depressant, neuro-
protective, cardio-protective, anti-diabetic, anti-cancer, anti-fungal, radio-protective, gastro-protective, 
and antioxidant activities. Studies on its pharmacokinetic (PK) properties revealed that it is a stable 
compound with no significant gender variation in its activities. Other significant details on its 
pharmacological properties and information for future investigations on its components are provided. 
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Natural products have recently attracted much 
attention in drug discovery and food supplement 
research   because they are frequently used due 
to their chemical diversity and potent 
bioactivities. Flavonoids are plant polyphenols 
found in herbs, vegetables and fruits. They are 
well known for their hepatoprotective, 
cardioprotective, antipyretic, analgesic, and anti-
inflammatory activities [1]. Flavonoids comprise a 
large group of polyphenolic with a benzo-γ-
pyrone structure. They are synthesized by the 
phenylpropanoid pathway. Available reports 
show that secondary phenolic metabolites 
including flavonoids are responsible for a variety 
of pharmacological activities [2]. 
 
Hyperoside (Figure 1), also known as quercetin-
3-O-D-galactoside, is a flavonol glycoside 
present in a variety of vegetables and fruits [3,4]. 
It has been isolated from various medicinal 
plants such as Hypericum perforatum[5], 
Ligularia fischeri [6], Crataegus davisii [7], 
Divaricate saposhnikovia [8] and Hypericum 
mysorense [9]. Hyperoside is associated with 
several potent pharmacological activities which 
include anti-inflammatory, anti-thrombotic, anti-
diabetic, anti-viral, anti-fungal, hepato-protective, 




Figure 1: Chemical structures of hyperoside(1) and 
quercetin (2) 
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           Table 1: Pharmacological activities of hyperoside 
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PHARMACOLOGICAL APPLICATIONS OF 
HYPEROSIDE 
 
Anti-inflammatory Activity  
 
Hyperoside exhibited anti-inflammatory activity in 
mouse ear edema, with inhibition of arachidonic 
acid-induced edema by more than 15 %, and 
crotonoil-induced edema by 19-25 % [15]. When 
mixed with isoquercitrin it produced anti-
inflammatory activity against carrageen-induced 
hind paw edema in albino mice, with 30 % 
inhibition for 6 h [16]. This phytochemical  
isolated from the leaves of Tripodanthus 
acutifolius has been reported to produce its anti-
inflammatory effect by inhibiting cyclooxygenase-
2 (COX-2) and hyaluronidase [17]. Hyperoside 
suppressed vascular inflammatory processes 
caused by high glucose level in the human 
umbilical vein endothelilal cells (HUVECs) and in 
mice [18]. It  suppresses the production of 
interleukin-6 (IL-6), tumor necrosis factor (TNF) 
and nitric oxide (NO) in lipopolysaccharide (LPS) 
-stimulated mouse peritoneal macrophages 
[17,19]. 
 
Anti-nociceptive activity  
 
Studies have shown that hyperoside exhibits 
analgesic activity by down regulating calcium 
(Ca2+) concentrations in afferent nerve endings 
[18,20]. It has anti-nociceptive activity in p-
benzoquinone-induced abdominal constriction in 




Hyperoside isolated from Apocynum venetum 
leaves has been shown to exhibit excellent anti-
depressant activity. In vitro study confirmed that 
2.5-10 μg/ml of the compound shielded PC12 
cells from the lesions and high influx of 
intracellular Ca2+ induced by corticosteroid (10 
μM). Its ability to boost brain-derived 
neurotrophic factor (BDNF) and cAMP response 
element binding protein (CREB) has also been 
reported [21]. In mice orally administered 
hyperoside at doses of 10-30 mg/kg for 10 days,  
antidepressant-like activity was noticed in 
suspension test (TST) and forced swimming test 
(FST) that may be affected in their interaction 
with serotonergic (5-HT2A and 5-HT2) systems 
[20,22]. Antidepressant-like effects of hyperoside 
have also been observed in forced swimming 
tests in rats. The antidepressant effect in rats 
was prevented by the administration of sulpiride 
(D2-antagonist). Evidence indicates that the 
antidepressant effect of hyperoside is mediated 




In vitro studies have shown that pretreatment 
with hyperoside (0.01-1 µmol/L) for 4 h 
decreased apoptosis in PC12 cells induced by 
sodium azide (20 µM).This neuro-protective 
action has been attributed to inhibition of ROS 
production [22,24]. At 5-20 µM, hyperoside 
protected primary rat cortical neuron from 
neurotoxcity of β-amyloid protein (Aβ) induced by 
sodium azide at 20 µM for 24 h. Thus, 
hyperosdie could be a useful therapeutic remedy 
for Alzheimer’s disease (AD) and other 
neurodegenerative diseases [23,25]. 
Furthermore, in in vitro ischemic models of 
oxygen–glucose deprivation followed by 
reperfusion (OGD-R), it was observed that 
hyperoside offered protection from ischemic 
neuron damage by nitric oxide signaling process 
[26]. It has also been reported that hyperoside 
attenuates neuronal apoptosis triggered by L-
glutamate through inhibition of NR2B-containing 
N-methyl-D-aspartate (NMDA) subtype of 
glutamate receptors [27]. At 16 µM it has been 
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shown to effectively reduce elevated levels of NO 
and Ca2+ from 34.4 µM and 640 nM to 25.0 µM 
and 331 nM in brain cells, respectively. 
Hyperoside also reduces the level of neuronal 
damage caused by anoxia as a result of 
increased concentration of NO and Ca2+ in brain 
cells [28]. 
 
Protective activity on brain 
 
Hyperoside at 1~10 µM reduced the degree of 
cerebral injury induced by oxygen-glucose 
deprivation followed by reperfusion [29].This 
provided protective effect on focal brain 
ischemia-reperfusion injury and restrained brain 
edema in rats [30].Moreover, it was observed 
that hyperoside has  protective effect on focal 
brain ischemia and reperfusion injury induced by 
oxidative damage in  rats [31]. Furthermore, it 
was observed that brain tissues treated with this 
compound  had lower water content [32]. Another 
study revealed that it shields rats from brain 
ischemia-reperfusion injury and protects them 
from cognitive disability [33]. 
 
Cardiovascular protective activity 
 
Hyperoside at 25 and 50 mg/kg protected rats 
from cardiomyocyte apoptosis caused by 
ischemia and perfusion, and at 0.50 μmol/L 
protected cultured rat neonatal cardiomyocyte 
from apoptosis [34]. It was also reported that 
hyperoside suppressed levels of 
malonodialdehyde (MDA) and NO in the 
myocardium, but increased the level of 
superoxide dismutase(SOD) [35]. It has also 
been reported that hyperoside protects 
cardiomyocytes from oxidative stress caused by 
ischemia and perfusion through significant up-
regulation of extracellular signal-regulated 
protein kinase (ERK) [36]. Hyperoside inhibited 
vascular lesions produced in a carotid artery 
ligation rat model [37]. It also possesses 
anticoagulant effects, as demonstrated through 
its capacity to restrain the production of thrombin 
and activated factor X (FXa), and extension of 
activated partial thromboplastin time (aPTT) and 
prothrombin time (PT) as well as inhibition of 




Hyperoside is well regarded for its anti-diabetic 
effects. It has been reported that hyperoside from 
Rhododendron arboretum and Crataegus 
pinnatifida exhibited anti-diabetic activity in 
streptozotocin-induced diabetic rats [38,39]. 
Methanolic extract of Artemisia capillaris which 
contains hyperoside has been reported to show 
excellent α-glucosidase inhibitory action [40]. In a 
molecular docking studies, it was shown that 
hyperoside could be an effective docking agent 




In an in vitro study on osteosarcoma cells, 
hyperoside was reported to restrain the growth of 
U2OS osteosarcoma cell lines (IC50 value 223.5 
± 9.5 µg/ml for 72 h) and MG63 ( IC50 value 239 
± 22.4 µg/ml for 72 h) by revitalizing the G0/G1 
arrest in cell cycle [42]. In addition, hyperoside in 
combination with Quercetin produced anti-cancer 
effects in 786-O renal cancer cells (IC50 value 
18.2, 18.7,11.8µg/ml at 48, 72 and 96 h) [43]. 
 
Antiviral activity  
 
Hyperoside from Abelmoschus manihot (L) 
medik inhibited the production of HBeAg and 
HBsAg by hepatitis B virus (HBV)-producing 
2.2.15 cells, and inhibited the duck hepatitis B 
virus (DHBV)-DNA levels in HBV- infected duck 
models [2]. Its antiviral activity was investigated 
in covalently-closed circular DNA (cccDNA) of 
duck hepatitis B virus [44]. Yinqiaosan powder 
which contains hyperoside is known to possess 




Hyperoside isolated from Artemisia Capillaris has 
been reported to protect mice from liver damage 
induced by carbon tetrachloride (CCl4). 
Furthermore, it increased inducible nitric oxide 
synthase (iNOS), hemeoxygenase-1 (HO-1) and 
mRNA expression of tumor necrosis factor-R 
(TNF-R) [46].  
 
Antioxidant activity  
 
Hyperoside protected PC12 cells against 
cytotoxicity induced by hydrogen peroxide (H2O2) 
and tert-butylhydroperoxide (t-BuOOH), and also 
protected lung fibroblast cells from oxidative 
stress induced by H2O2  [47].   
 
Moreover, hawthorn fruit extract containing 
hyperoside has been reported to attenuate 
oxidative damage by protecting mouse bone 
marrow cells from genotoxicity caused by 
cyclophosphamide [3]. It also protected hepatic 
L02 cells and HUVEC cells from oxidative 
damage induced by H2O2 [48,49]. Recently 
hyperoside isolated from lotus seed epicarp 
showed significant DPPH and ABTS+ radical 
scavenging activities [50]. 
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Hyperoside has been shown to exhibit immuno-
modulatory activity in mice in non-specific, 
cellular and humoral immunity tests. In carbon 
clearance test (non-specific immunity), clearance 
index at doses of 12.5, 25 and  50 mg/kg was 
enhanced 34.6 %, 7.7 % and 7.7 %, respectively, 
and phagocytic index was increased by 18.3 %, 
12.9 % and 2.1 % respectively when compared 
to normal group. In lymphocyte proliferation test, 
lymphocyte proliferation was elevated by 
hyperoside action [51]. It also raised the 
concentration of effector T helper cells secreting 
cytokines in mouse spleen lymphocytes [44]. 
 
Inhibitory activity against cytochrome 
P450(CYP) isoform  
 
It has been reported that hyperoside inhibits 
different isoforms of CYP, especially CYP2D6 
[52].  
 
Other activities of hyperoside 
 
Hyperoside has remarkable antifungal effect 
against Pestalotia guepinii, Drechslera sp. and 
Fusarium avenaceum [11]. It protected mice from 
gastric mucosal damage induced by ethanol via 
its anti-oxidant properties, as well as reduction of 
NO level in gastric mucosal tissues [53]. It 
decreased the formation of calcium oxalate 
stones in rat kidney [54] and diminished renal 
fibrosis in vivo [55]. Hyperoside also shielded 
hamster lung fibroblast cells from gamma ray 
radiation-stimulated apoptosis [56] and inhibited 
ultraviolet B (UVB) -stimulated transactivation of 
activator protein-1(AP-1), as well as mitogen-
activated protein kinase signaling 
pathway(ERK1/2) in JB6 P+ mouse epidermal 
cells line [57]. 
 
Pharmacokinetics of hyperoside 
 
In vitro studies show that hyperoside is a stable 
compound. In an oral absorption study of this 
compound and isoquercetrin in rats, it was 
demonstrated that isoquercetrin was more easily 
hydrolyzed to its aglycone moiety in the 
gastrointestinal tract than hyperoside, and that in 
vitro, it was more stable than isoquercetrin [58]. 
In another study, binding interaction between 
hyperoside and bovine serum albumin (BSA) 
was investigated by fluorescence spectroscopy 
[59]. Fluorescence spectroscopy data was 
examined with the aid of Tachiya model and 
Stern–Volmer equation. Tachiya model equation 
revealed that the binding sites and binding 
constants were increased with increase in 
temperature. On the other hand, Stern-Volmer 
equation showed that binding constants reduced 
with temperature elevation, although the binding 
sites were independent of temperature. The 
binding of hyperoside to bovine serum albumin  
was enhanced in the presence of Cu2+, Ca2+, 
Zn2+ and K+ but  decreased when Mg2+ was 
present [59]. When hyperoside and 3'-O-methyl-
hyperoside were administered through gastric 
probe and intraperitoneal (i.p.) route to rats, it 
was observed that hyperoside and 3'-O-methyl-
hyperoside were present in rat brain after i.p. 
administration, but were not detected when 
administered by gastric probe [60]. In another 
pharmacokinetic profile study of  hyperoside in 
male and female dogs, it was shown that sex has 





For this review, a number of scientific databases 
(Science Direct, ISI Web of Knowledge, Google 
Scholar and China Knowledge Resource 
Integrated Database) were employed to access 
information. Research articles published in both 
English and Chinese languages were included. 
According to available information, hyperoside 
from different fruits and vegetables has become 
important due to its numerous pharmacological 
activities such as anti-inflammatory, anti-
analgesic, neuro-protective, anti-coagulant, anti-
diabetic, anti-cancer, anti-viral, anti-fungal, and 
anti-oxidant activities. The information presented 
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